James Andrew Nathanielsz - 17 Aug 2021 Form 4 Insider Report for Propanc Biopharma, Inc. (PPCB)

Role
CEO/CFO, Director
Signature
/s/ James Nathanielsz
Issuer symbol
PPCB
Transactions as of
17 Aug 2021
Net transactions value
$0
Form type
4
Filing time
20 Aug 2021, 06:15:17 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PPCB Common stock, par value $0.001 Award $0 +5,928,000 +148200000% $0.000000 5,928,004 17 Aug 2021 North Horizon Investments Pty Ltd. as Trustee for Nathanielsz Family Trust
transaction PPCB Common stock, par value $0.001 Award $0 +2,800,000 $0.000000 2,800,000 17 Aug 2021 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.